Two distinct genes encode the 93% homologous type 1 (placenta, peripheral tissues) and type 2 (adrenals, gonads) 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD/isomerase) in humans. enzyme. Dixon analysis shows that epostane inhibits the 3β-HSD activity of the wild-type 1 enzyme with 14 to17-fold greater affinity compared to the wild-type 2 and H156Y enzymes. The Y154F and K158Q mutants exhibit no 3β-HSD activity, have substantial isomerase activity and utilize substrate with K m values similar to those of wild-type 1 isomerase. The Y269S and K273Q mutants have low, pH-dependent 3β-HSD activity, exhibit only 5% of the maximal isomerase activity and utilize the isomerase substrate very poorly. From these studies, a structural basis for the profound differences in the substrate and inhibition kinetics of the wildtype 1 and 2 3β-HSD plus a catalytic role for the Tyr 154 and Lys 158 residues in the 3β-HSD reaction have been identified. These advances in our understanding of the structure/function of human type 1 and 2 3β-HSD/isomerase may lead to the design of selective inhibitors of the type 1 enzyme not only in placenta to control the onset of labor but also in hormone-sensitive breast, prostate and choriocarcinoma tumors to slow their growth.
INTRODUCTION
The human type 1 (placenta, skin, mammary gland, prostate, endometrium) and type 2 (gonads, adrenals) isoforms of 3ß-hydroxysteroid dehydrogenase (EC 1.1.1.145)/steroid ∆ 5 -∆ 4 -isomerase (EC 5.3.3.1) (3ß-HSD/isomerase 1 ) are encoded by two distinct genes which are expressed in a tissue-specific pattern (1) . In human placenta, type 1 3ß-HSD/isomerase catalyzes the conversion of 3ß-hydroxy-5-ene-steroids (dehydroepiandrosterone, pregnenolone) to 3-oxo-4-ene-steroids (androstenedione, progesterone) on a single, dimeric protein containing both enzyme activities (2) . During human pregnancy, the placental enzyme catalyzes the conversion of pregnenolone to progesterone, which maintains the uterus in a quiescent state. Near term, however, the fetal zone adrenal gland produces large amounts (200 mg/day) of dehydroepiandrosterone (DHEA, Figure 1 ). Because the fetal adrenal lacks significant 3ß-HSD/isomerase activity, the placental type 1 enzyme converts the fetal dehydroepiandrosterone to androstenedione (3) . Androstenedione is converted by placental aromatase and 17β-hydroxysteroid dehydrogenase to estradiol, which participates in the cascade of events that initiates labor in humans (4). The type 1 enzyme also is selectively expressed in human breast tumors (5) , prostate tumors (6) , and choriocarcinomas (7) , where it catalyzes the first step in the conversion of circulating dehydroepiandrosterone to the tumor growth-promoting hormone, estradiol or testosterone. Determination of the structure/function relationships of the type 1 enzyme may lead to the development of specific inhibitors of type 1 3ß-HSD/isomerase that can help control the timing of labor and slow the growth of hormonesensitive tumors.
The Y-X-X-X-K motif has been conserved in the short-chain dehydrogenase/reductase family of enzymes and participates in the catalytic mechanisms of rat liver 11$-HSD (8),
Streptomyces hydrogenans 3",20$-HSD (8) , Drosophila alcohol dehydrogenase (9) , E. Coli 7"-HSD (10) , and human 17$-HSD (11) . In each of these enzymes, there is a single Y-X-X-X-K motif associated with the dehydrogenase activity, but there are two of these motifs ( 154 Y-X-X-Xby guest on November 6, 2017 http://www.jbc.org/ Downloaded from K 158 and 269 Y-X-X-X-K 273 ) in the primary structures of human type 1 and type 2 3$-HSD/isomerase ( Figure 2 ) (12) . 3ß-HSD/isomerase is an ideal enzyme system to study using site-directed mutagenesis because an appropriately targeted point mutation will primarily affect only one of the two activities. If both activities are abolished, the mutation most likely has induced a nonspecific conformational change in the enzyme protein.
In the current study, we have used site-directed mutagenesis to produce four mutated forms of human type 1 3ß-HSD/isomerase that target the potentially critical residues in the two Y-X-X-X-K motifs (Y154F, K158Q, Y269S, K273Q). In addition, the H156Y mutant was created to produce a chimera of 
Expression and purification of the mutant and wild-type enzymes
The mutant 3ß-HSD cDNA was introduced into baculovirus as previously described (13, 14) . Recombinant baculovirus was added to 1.5 x 10 9 Sf9 cells (1L) at a multiplicity of infection of 10 for expression of each mutant enzyme. The expressed mutant and wild-type enzymes were separated by SDS-polyacrylamide (12%) gel electrophoresis, probed with our anti-3$-HSD polyclonal antibody and detected using the ECL western blotting system with antirabbit, peroxidase-linked secondary antibody (Amersham Pharmacia Biotech, Piscataway, NJ). Each expressed enzyme was purified from the 100,000 g pellet of the Sf9 cells (2 L) by our published method (2) . The Emulgen 913 detergent (polyoxyethylene (13) (14) 
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The wild-type 1 cDNA mutants (Y154F, H156Y, K158Q, Y269S, K273Q) were produced by double-stranded, PCR-based mutagenesis and inserted into baculovirus as described in Methods. As shown by the immunoblot in Figure 3 , the baculovirus system successfully expressed the mutant enzyme proteins as well as the human wild-type 1 and wild-type 2 3$-HSD/isomerase in Sf9 cells. Each expressed enzyme was purified using our published method (2) to apparent homogeneity according to SDS-PAGE ( Figure 4 ). An additional mutant, Y269F, was created and expressed, but western immunoblots showed that this mutant enzyme was unstable.
Kinetic Analyses of the Wild-Type and Mutant Enzymes
The Michaelis-Menten kinetic values measured for substrate utilization by purified wildtype 1, wild-type 2 and mutant variations of human 3$-HSD/isomerase are summarized in Table   2 . Purified human type 1 placental 3$-HSD/isomerase has been previously shown to have
Michaelis-Menten constants for substrate steroid and cofactors that were almost identical to those measured for expressed, purified wild-type 1 enzyme (13 The cofactor kinetics of the purified mutant and wild-type enzymes (Table 4 ) mirror the substrate kinetics in Table 2 with some important distinctions. Wild-type 1 3$-HSD has 2-fold lower K m and K cat values than those of the wild-type 2 3$-HSD. Clearly, these differences in NAD + kinetics are much less dramatic than the differences in the substrate kinetics measured for the wild-type 1 and 2 3$-HSD (Tables 2 and 3 Because there are two Y-X-X-X-K motifs in human type 1 3$-HSD, the pH-dependency of the residual 3$-HSD activities of the Y154F, K158Q, Y269S and K273Q mutants can help assess which motif is involved in catalysis. If the residual dehydrogenase activity of the mutant enzyme is pH-dependent, the substituted amino acid must not be catalytic because the residual activity has to be due to a different amino acid in the enzyme (18) . Although 3$-HSD activity is undetectable for each of these mutant enzymes using DHEA as substrate (Table 2 ), the use of 5"-androstan-3$-ol-3-one as substrate enhances residual 3$-HSD by 3-fold to detectable levels.
The 3$-hydroxy-5"-reduced steroid is not a substrate for isomerase activity, so feedback inhibition by a 3-keto-4-ene product steroid (e.g., androstenedione) of 3$-HSD/isomerase does not limit the 3$-HSD activity (2,19). The extremely low residual 3$-HSD activities of these mutants allow a meaningful comparison only between pH 7.4 and the optimal pH 9.7. As shown in Table 5 , the Y269S and K273Q mutants exhibit low residual 3$-HSD activity at pH 7.4, and that activity is doubled at the optimal pH 9. retain the characteristics of the wild-type 1 enzyme. In addition, the optimal pH of the wild-type 1 3$-HSD activity is shifted from pH 9.7 to the pH 9.0 optimum of the wild-type 2 3$-HSD by the H156Y mutation. However, the different pH optima are not directly responsible the differences in the kinetic profiles of the wild-type 1, wild-type 2 and H156Y enzymes. All substrate and inhibition kinetic studies were performed at pH 7.4, at which the percent maximal 3$-HSD activity was equivalent for all three enzyme species. 
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